Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

被引:198
|
作者
Walker, Joan L. [1 ]
Powell, C. Bethan [2 ]
Chen, Lee-may [3 ]
Carter, Jeanne [4 ]
Jump, Victoria L. Bae [5 ]
Parker, Lynn P. [6 ]
Borowsky, Mark E. [7 ]
Gibb, Randall K. [8 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA
[2] Kaiser Permanente San Francisco, Northern Calif Gynecol Canc Program, San Francisco, CA USA
[3] Univ Calif San Francisco, Mt Zion Canc Ctr, Div Gynecol Oncol, San Francisco, CA 94143 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[5] Univ N Carolina, Div Gynecol Oncol, Chapel Hill, NC USA
[6] Norton Canc Inst, Louisville, KY USA
[7] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE USA
[8] Billings Clin, Ctr Canc, Billings, MT USA
关键词
BRCA; carriers; Cascade genetic testing; fallopian tube; genetic testing; mastectomy; ovarian cancer; oral contraceptives; prevention; salpingectomy; risk-reducing bilateral salpingo-oophorectomy (BSO); REDUCING SALPINGO-OOPHORECTOMY; BRCA MUTATION CARRIERS; QUALITY-OF-LIFE; FALLOPIAN-TUBE EPITHELIUM; PELVIC SEROUS CARCINOMA; ORAL-CONTRACEPTIVE USE; HIGH-RISK WOMEN; PROPHYLACTIC SALPINGECTOMY; BREAST-CANCER; LAPAROSCOPIC SALPINGECTOMY;
D O I
10.1002/cncr.29321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mortality from ovarian cancer may be dramatically reduced with the implementation of attainable prevention strategies. The new understanding of the cells of origin and the molecular etiology of ovarian cancer warrants a strong recommendation to the public and health care providers. This document discusses potential prevention strategies, which include 1) oral contraceptive use, 2) tubal sterilization, 3) risk-reducing salpingo-oophorectomy in women at high hereditary risk of breast and ovarian cancer, 4) genetic counseling and testing for women with ovarian cancer and other high-risk families, and 5) salpingectomy after childbearing is complete (at the time of elective pelvic surgeries, at the time of hysterectomy, and as an alternative to tubal ligation). The Society of Gynecologic Oncology has determined that recent scientific breakthroughs warrant a new summary of the progress toward the prevention of ovarian cancer. This review is intended to emphasize the importance of the fallopian tubes as a potential source of high-grade serous cancer in women with and without known genetic mutations in addition to the use of oral contraceptive pills to reduce the risk of ovarian cancer. Cancer 2015;121:2108-2120. (c) 2015 American Cancer Society.
引用
收藏
页码:2108 / 2120
页数:13
相关论文
共 50 条
  • [1] Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
    Rodriguez, Isabel V.
    Ghezelayagh, Talayeh
    Pennington, Kathryn P.
    Norquist, Barbara M.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1355 - 1366
  • [2] Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology
    Mikami, Mikio
    Nagase, Satoru
    Yamagami, Wataru
    Ushijma, Kimio
    Tashiro, Hironori
    Katabuchi, Hidetaka
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (04)
  • [3] Current Science and Practice of Surgical and Nonsurgical Opportunities for Ovarian Cancer Prevention
    MacArthur, Emily
    Stone, Rebecca
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2024, 67 (04) : 676 - 686
  • [4] Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
    Wright, Alexi A.
    Bohlke, Kari
    Armstrong, Deborah K.
    Bookman, Michael A.
    Cliby, William A.
    Coleman, Robert L.
    Dizon, Don S.
    Kash, Joseph J.
    Meyer, Larissa A.
    Moore, Kathleen N.
    Olawaiye, Alexander B.
    Oldham, Jessica
    Salani, Ritu
    Sparacio, Dee
    Tew, William P.
    Vergote, Ignace
    Edelson, Mitchell I.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 3 - 15
  • [5] Frontline PARP inhibitor maintenance therapy in ovarian cancer: A Society of Gynecologic Oncology practice statement
    Pothuri, Bhavana
    O'Cearbhaill, Roisin
    Eskander, Ramez
    Armstrong, Deborah
    GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 8 - 12
  • [6] Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
    Herzog, Thomas J.
    Armstrong, Deborah K.
    Brady, Mark F.
    Coleman, Robert L.
    Einstein, Mark H.
    Monk, Bradley J.
    Mannel, Robert S.
    Thigpen, J. Tate
    Umpierre, Sharee A.
    Villella, Jeannine A.
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 8 - 17
  • [7] Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review
    Chen, Lee-may
    Blank, Stephanie V.
    Burton, Elizabeth
    Glass, Karen
    Penick, Elizabeth
    Woodard, Terri
    GYNECOLOGIC ONCOLOGY, 2019, 155 (03) : 508 - 514
  • [8] Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
    Lancaster, Johnathan M.
    Powell, C. Bethan
    Chen, Lee-may
    Richardson, Debra L.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 3 - 7
  • [9] Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
    Tindale, Lauren C.
    Zhantuyakova, Almira
    Lam, Stephanie
    Woo, Michelle
    Kwon, Janice S.
    Hanley, Gillian E.
    Knoppers, Bartha
    Schrader, Kasmintan A.
    Peacock, Stuart J.
    Talhouk, Aline
    Dummer, Trevor
    Metcalfe, Kelly
    Pashayan, Nora
    Foulkes, William D.
    Manchanda, Ranjit
    Huntsman, David
    Stuart, Gavin
    Simard, Jacques
    Dawson, Lesa
    CURRENT ONCOLOGY, 2022, 29 (07) : 4632 - 4646
  • [10] Surgical prevention strategies in ovarian cancer
    Mallen, Adrianne
    Soong, T. Rinda
    Townsend, Mary K.
    Wenham, Robert M.
    Crum, Christopher P.
    Tworoger, Shelley S.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 166 - 175